BPTH
Price:
$1.11
Market Cap:
$4.78M
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing Liposomal Bcl-2 for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; Liposomal STAT3 that is in preclinical stage for ...[Read more]
Industry
Biotechnology
IPO Date
2008-03-04
Stock Exchange
NASDAQ
Ticker
BPTH
According to Bio-Path Holdings, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.24M. This represents a change of 87.77% compared to the average of 2.26M of the last 4 quarters.
The mean historical Enterprise Value of Bio-Path Holdings, Inc. over the last ten years is 46.57M. The current 4.24M Enterprise Value has changed 811.52% with respect to the historical average. Over the past ten years (40 quarters), BPTH's Enterprise Value was at its highest in in the March 2016 quarter at 226.01M. The Enterprise Value was at its lowest in in the March 2020 quarter at -883000.00.
Average
46.57M
Median
2.65M
Minimum
39.50K
Maximum
223.63M
Discovering the peaks and valleys of Bio-Path Holdings, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 4.49%
Maximum Annual Enterprise Value = 223.63M
Minimum Annual Increase = -96.76%
Minimum Annual Enterprise Value = 39.50K
Year | Enterprise Value | Change |
---|---|---|
2023 | 3.49M | 323.34% |
2022 | 823.76K | -54.60% |
2021 | 1.81M | 4.49% |
2020 | 39.50K | -96.76% |
2019 | 1.22M | 12.25% |
2018 | 1.09M | -92.49% |
2017 | 14.45M | -87.52% |
2016 | 115.77M | 12.02% |
2015 | 103.35M | -53.79% |
2014 | 223.63M | -20.68% |
The current Enterprise Value of Bio-Path Holdings, Inc. (BPTH) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
2.04M
5-year avg
1.48M
10-year avg
46.57M
Bio-Path Holdings, Inc.’s Enterprise Value is less than Catalyst Biosciences, Inc. (1.03B), less than Diffusion Pharmaceuticals Inc. (10.50M), less than Capricor Therapeutics, Inc. (575.76M), greater than NextCure, Inc. (4.04M), less than Pulmatrix, Inc. (10.26M), greater than Bellerophon Therapeutics, Inc. (-4235209.00), less than Crinetics Pharmaceuticals, Inc. (4.74B), greater than Applied Molecular Transport Inc. (-5743713.00), less than Aileron Therapeutics, Inc. (22.86M), less than Benitec Biopharma Inc. (193.32M), less than Onconova Therapeutics, Inc. (32.62M), greater than Moleculin Biotech, Inc. (-3378743.00), less than Achieve Life Sciences, Inc. (130.29M), less than Icosavax, Inc. (713.87M), less than Akari Therapeutics, Plc (10.29M),
Company | Enterprise Value | Market cap |
---|---|---|
1.03B | $19.42M | |
10.50M | $8.98M | |
575.76M | $642.49M | |
4.04M | $26.35M | |
10.26M | $21.04M | |
-4235209.00 | $146.79K | |
4.74B | $5.00B | |
-5743713.00 | $11.01M | |
22.86M | $40.52M | |
193.32M | $260.95M | |
32.62M | $20.90M | |
-3378743.00 | $5.52M | |
130.29M | $129.99M | |
713.87M | $769.04M | |
10.29M | $11.54M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bio-Path Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bio-Path Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Bio-Path Holdings, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Bio-Path Holdings, Inc. (BPTH)?
What is the 3-year average Enterprise Value for Bio-Path Holdings, Inc. (BPTH)?
What is the 5-year average Enterprise Value for Bio-Path Holdings, Inc. (BPTH)?
How does the current Enterprise Value for Bio-Path Holdings, Inc. (BPTH) compare to its historical average?